Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris|June 18, 1981
[Effects of chronic administration of lithium on thyroxine (T4), triiodothyronine (T3), reverse T3 (rT3) free thyroxine ratio (FTR) and thyreostimuline (TSH) in thyrotoxicosis (author's transl)]J Heim, Y Lorcy, E Auvray, et al.
Pathologie-Biologie|December 1, 1986
[Methodological problems in the determination of microalbuminuria]M Krempf, P Peltier, G Ricolleau, et al.
Annales De Biologie Clinique|June 26, 2004
[Manufacture of DNA chips in a laboratory for internal use: legislation and quality assurance]P Jézéquel, J Pichon, F Magrangeas, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1984
Radioimmunoassay of the CA 12 5 antigen in ovarian carcinomas: advantages compared with CA 19-9 and CEAG Ricolleau, J F Chatal, P Fumoleau, et al.
European Journal of Cancer (Oxford, England : 1990)|August 26, 1998
Quantitative determination of c-erbB-2 in human breast tumours: potential prognostic significance of low valuesS Koscielny, P Terrier, A Daver, et al.
International Journal of Cancer|January 17, 1995
Clinical validation of the new ELSA-CA 125 II assay: report of a European multicentre evaluationM Clement, P Bischof, C Gruffat, et al.
British Journal of Cancer|June 11, 2009
Validation of UBE2C protein as a prognostic marker in node-positive breast cancerD Loussouarn, L Campion, F Leclair, et al.
British Journal of Cancer|July 17, 1999
Prognostic value of uPA and p53 accumulation measured by quantitative biochemical assays in 1245 primary breast cancer patients: a multicentre studyP Broët, F Spyratos, S Romain, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2001
Thymidine kinase as a proliferative marker: clinical relevance in 1,692 primary breast cancer patientsP Broët, S Romain, A Daver, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 16, 2007
Change in CA 125 levels after the first cycle of induction chemotherapy is an independent predictor of epithelial ovarian tumour outcomeJ M Riedinger, F Bonnetain, J P Basuyau, et al.
Pageof 2